Founded in 2017 by two respiratory clinicians following 11 yrs of NHS-led and funded research.
To improve the lives of people with COPD through life-changing digital predictive solutions that prevent 50% of COPD-related hospitalisations and re-admissions.
To be a global leader in personalised prediction and prevention of COPD exacerbations: making a difference to the lives of people with COPD
Clinical studies demonstrated 97% reduction in hospital admissions using predict to prevent intervention as part of proactive self-management.
Patients, clinicians, hospitals, policy makers and Industry provide a robust eco-system to ensure our products remain cutting edge and competitive.
“I found it very straightforward… I’m not brilliant with electronics but yes I found it very easy very straightforward”
“I like to share my progress with my family …it gives them greater understanding of my condition”
“One of the things that I found most useful was to see the results of my daily diary , my results in graphic form, so easy to see”
“I’m more confident about my self-management”
“before I didn’t even look at the colour of my sputum or think about how I feel but I do now”
“it gives you more confidence and direction”
Respiratory physician with 30 yrs+ experience working in the NHS. Named inventor on patents. Held executive leadership roles in European Respiratory and British Thoracic Societies. External advisor, EC Horizon 2020 Personalising Healthcare and various pharmaceutical companies.
Respiratory physician, named inventor on patents. 10 years’ experience in managing project finances/records and research background in saliva diagnostics and prediction algorithm construction.
Experienced founder of UK start-up SW company. 15 years+ experience in innovative software solutions and specialist in AI and IoT driven applications in healthcare.
30 yrs+ experience in pharmaceutical industry, including extensive corporate development roles. Was ex-COO Vectura Group PLC, playing key role in Activaero GmbH acquisition & Skyepharma merger. Currently, CEO Open Orphan Plc.
Extensive US and international commercialisation experience in a number of senior roles, including vice president sales and marketing of the US publicly held company Critical Therapeutics, Inc. and vice president, director of client service at McK Healthcare. Currently, EVP of Commercial and Business Development at Vectura Group plc.
76 King Street,
Manchester, M2 4NH,
70 Conduit Street, London,
W1S 2GF, United Kingdom